Calgary, AB - TheNewswire - March 16, 2023 - Universal Ibogaine Inc. ( TSXV:IBO ) (“ UI ” or the “ Company ”), a life sciences company with a mission to deliver medicalized ibogaine-centered addiction care, advises that following preliminary approval by the TSX Venture Exchange (the “TSXV”), it has slightly modified the terms of its pending offering of convertible debt securities (the “ Offering ”, as was described in the Company’s prior [...]

Calgary, AB – TheNewswire - February 6, 2023 – Universal Ibogaine Inc. ( TSXV:IBO ) (“ UI ” or the “ Company ”), a life sciences company with a mission to deliver medicalized ibogaine-centered addiction care, advises that it is in process of finalizing an offering of convertible debt securities (the “ Offering ”).  The Offering consists of up to $5 million of “Secured Guarantee Convertible Notes” (the “ Notes ”) which [...]

Calgary, AB – TheNewswire - January 23, 2023 – Universal Ibogaine Inc. ( TSXV:IBO ) (“ UI ” or the “ Company ”), a life sciences company with a mission to deliver medicalized ibogaine-centered addiction care, advises that it’s addiction and mental health treatment clinic, the Kelburn Recovery Center (“ Kelburn ”), which operates near Winnipeg, Manitoba via a wholly-owned subsidiary of UI, has re-opened effective January 23, 2023. Dr. [...]

Calgary, AB – TheNewswire - January 4, 2023 – Universal Ibogaine Inc. ( TSXV:IBO ) (“ UI ” or the “ Company ”), a life sciences company with a mission to transform the addiction treatment industry with medicalized ibogaine-centered care, is pleased to provide a year end summary of 2022 accomplishments. Nick Karos, Chief Executive Officer and board member of [...]

Calgary, AB – TheNewswire - December 9, 2022 – Universal Ibogaine Inc. ( TSXV:IBO ) (“ UI ” or the “ Company ”), a life sciences company with a mission to deliver medicalized ibogaine-centered addiction care, announces that it has agreed to issue 350,000 common shares (at a deemed price of $0.05) as part of a settlement agreement related to a claim filed in August 2021 by a [...]

Calgary, AB – December 1, 2022 – Universal Ibogaine Inc. ( TSXV:IBO ) (“ UI ” or the “ Company ”), a life sciences company with a mission to deliver medicalized ibogaine-centered addiction care, advises that it is in process of finalizing an offering (the “ Offering ”) of convertible debt securities.  The Offering will consist of “Secured Guarantee Convertible Notes” (the “ Notes ”) which will bear interest at [...]

Vancouver, BC / December 1, 2022 / Universal Ibogaine Inc. (the “Company”) (TSXV: IBO) is pleased to announce that it has closed its non-brokered private placement of convertible notes (the “Notes”) previously announced on October 3, 2022. (the “Debt Offering”) The Company has issued Notes in the aggregate principal amount of $626,500 CAD. The Notes shall mature 3 years from [...]

Calgary, AB – TheNewswire - November 08, 2022 – Universal Ibogaine Inc. ( TSXV:IBO ) (“ UI ” or the “ Company ”), a life sciences company with a mission to deliver medicalized ibogaine-centered addiction care, is pleased to announce the formation of an external Advisory Board as part of its strategic plans and mission to deliver medicalized ibogaine-centered addiction care and to undertake a planned clinical trial [...]

Calgary, AB – TheNewswire - October 5, 2022 – Universal Ibogaine Inc. ( TSXV:IBO ) (“ UI ” or the “ Company ”), a life sciences company with a mission to deliver medicalized ibogaine-centered addiction care, is pleased to announce that all resolutions were passed by the requisite majority of shareholders at its annual general meeting (“ AGM ”) which was held on October 3, 2022 in Vancouver, BC. UI’s five incumbent [...]

Calgary, AB – TheNewswire - October 3, 2022 – Universal Ibogaine Inc. ( TSXV:IBO ) (“ UI ” or the “ Company ”), a life sciences company with a mission to deliver medicalized ibogaine-centered addiction care, advises that it is in process of finalizing an offering (the “ Offering ”) of convertible debt securities.  The Offering will consist of “Secured Guarantee Convertible Notes” (the “ Notes ”) which will bear interest at 8% (payable [...]